Mechanisms and therapeutic prospects of diabetic cardiomyopathy through the inflammatory response

N Kaur, Y Guan, R Raja, A Ruiz-Velasco… - Frontiers in …, 2021 - frontiersin.org
The incidence of heart failure (HF) continues to increase rapidly in patients with diabetes. It
is marked by myocardial remodeling, including fibrosis, hypertrophy, and cell death, leading …

Cathepsin C inhibitors as anti-inflammatory drug discovery: Challenges and opportunities

XB Shen, X Chen, ZY Zhang, FF Wu, XH Liu - European Journal of …, 2021 - Elsevier
Cathepsin C, an important lysosomal cysteine protease, mediates the maturation process of
neutrophil serine proteases, and participates in the inflammation and immune regulation …

Circulating neutrophil‐related proteins associate with incident heart failure and cardiac dysfunction: The ARIC study

LF Buckley, P Dorbala, BL Claggett… - European Journal of …, 2023 - Wiley Online Library
Aims Neutrophil activity contributes to adverse cardiac remodelling in experimental acute
cardiac injury and is modifiable with pharmacologic agents like colchicine. Methods and …

Identification and verification of immune-related biomarkers and immune infiltration in diabetic heart failure

Z Zhong, H Zhang, T Xu, J Hao, X Chen… - Frontiers in …, 2022 - frontiersin.org
Purpose Diabetic heart failure (DHF) or cardiomyopathy is a common complication of
diabetes; however, the underlying mechanism is not clear. In the present study, the authors …

Hindrance of the proteolytic activity of neutrophil-derived serine proteases by serine protease inhibitors as a management of cardiovascular diseases and chronic …

T Burster, Z Mustafa, D Myrzakhmetova… - Frontiers in …, 2021 - frontiersin.org
During inflammation neutrophils become activated and segregate neutrophil serine
proteases (NSPs) to the surrounding environment in order to support a natural immune …

SIRT6‑specific inhibitor OSS‑128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress

Y Huang, J Zhang, D Xu, Y Peng… - Molecular …, 2021 - spandidos-publications.com
Diabetic cardiomyopathy (DCM) is a serious complication of diabetes, which importantly
contributes to the increased mortality of patients with diabetes. The development of DCM is …

[HTML][HTML] In vivo and in vitro studies of Danzhi Jiangtang capsules against diabetic cardiomyopathy via TLR4/MyD88/NF-κB signaling pathway

H Shi, P Zhou, Y Ni, S Wang, R Song, A Shen… - Saudi Pharmaceutical …, 2021 - Elsevier
Abstract Objectives Danzhi Jiangtang capsule (DJC) is widely used for preventing and
treating diabetic cardiomyopathy (DCM). However, the underlying mechanisms of the anti …

[HTML][HTML] Astragaloside IV protects diabetic cardiomyopathy against inflammation and apoptosis via regulating TLR4/MyD88/NF-κB signaling pathway

L Wang, H Shi, C Zhao, J Li, J Peng, A Shen… - Journal of Functional …, 2022 - Elsevier
Inflammatory response-mediated excessive apoptosis is the main pathological alteration in
the development of diabetic cardiomyopathy (DCM). The role of astragaloside IV (AS-IV) in …

Leukocyte infiltration and cross-talk with cardiomyocytes exploit intracellular stress pathways in dilated cardiomyopathy of idiopathic origin

D Talukdar, AK Haldar, S Kumar, R Dastidar… - Molecular Biology …, 2024 - Springer
Background and objective Dilated cardiomyopathy (DCM) is a prevalent form of heart failure
results in dilation and disruption of heart. Most strikingly a majority of the DCM cases do not …

Genetics of Cardiac Aging Implicate Organ-Specific Variation

J Brundage, JP Barrios, GH Tison, JP Pirruccello - medRxiv, 2024 - pmc.ncbi.nlm.nih.gov
Heart structure and function change with age, and the notion that the heart may age faster
for some individuals than for others has driven interest in estimating cardiac age …